Interna Technologies B.v.

Koninklijke Nederlandse Akademie Van Wetenschappen

Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg

Intera Technologies B.v.

Grégoire Pierre André Prevost

Roeland Quirinus Jozef Schaapveld

Willemijn Maria Gommans

Eugene Berezikov

Rick Jan Van Haastert

Jos Bernard Poell

Andreas Alphons F L Van Puijenbroek

Petronella Innocentia Van Noort

Matheus Maria De Gunst

Iman Johannes Schultz

Rudolf Henrikus Brakenhoff

Marlon Van Der Plas

Sanne Rosaly De Kemp

Francesco Cerisoli

The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.

MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway

The invention relates to the therapeutic use of a combination in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.

Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway

The invention relates to the diagnostic and therapeutic uses of a miRNA-323, miRNA-342, miRNA-326, miRNA-371, miRNA-3157 and/or miRNA-345 molecule, an equivalent or a source thereof in a disease and condition associated with a squamous cell carcinoma such as head and neck cancer or a preneoplastic mucosal change.

MiRNA for treating head and neck cancer

Growing community of inventors

Antony, France

Grégoire Pierre André Prevost